BIOE 301: Lecture 22 Role of the Food and Drug Administration Nadhi Thekkek Department of Bioengineering, Rice University April 8, 2008 Rice University.

Slides:



Advertisements
Similar presentations
Regulatory Pathway for Platform Technologies
Advertisements

Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
What’s NIH? National Cancer Institute National Eye Institute National Heart, Lung, and Blood Inst. National Human Genome Research Inst National Institute.
BIOE 301 Lecture 19.
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
Clinical Trials Medical Interventions
Introduction to Regulation
American Evaluation Association EVALUATION 2011 November 3, 2011 Approaches to Biomedical Research and Development Portfolio Analysis: Examples From the.
Pharmaceutical Development and Review Process Rev. 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
Medical Devices Approval Process
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
 2011 Johns Hopkins Bloomberg School of Public Health Regulation of Tobacco Products Mitch Zeller, JD Pinney Associates.
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
Investigational New Drug Application 21 CFR Part 312 A Review for OCRA US RAC Study Group September 2005 Ginger Clasby, MS Promedica International
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
NIH OBSSR Summer Institute July 2012 National Institutes of Health U.S. Department of Health and Human Services Overview of the NIH Peer Review Process.
Stages of drug development
Therapeutic Goods Administration An introduction to the work of Australia’s regulator of therapeutic goods.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 3 Drug Regulation, Development, Names, and Information.
Short Overview of the NIH SBIR/STTR Program “Lab to Life”
1 THE UNIQUE ROLES OF IRB IN MEDICAL DEVICE CLINICALL TRIAL Chiu Lin, Ph.D. CITI, May, 2009 CITI, May, 2009.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Yesterday, today, and tomorrow
Lecture Nineteen Biomedical Engineering for Global Health.
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
NIAID Commitment to Influenza Research and Preparedness F. Gray Handley Associate Director for International Research Affairs National Institute of Allergy.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
Investigational New Drug Application (IND)
REGULATORY CHALLENGES FOR NANOMATERIALS IN PUBLIC HEALTH Driving Faster Than Our Nano-Headlights AAAS Annual Meeting February 13, 2009 Norris E. Alderson,
BME 301 Lecture Twenty-Two. How are health care technologies managed? Examples: MRI Laparoscopic cholecystectomy Vitamin C treatment for scurvy Research.
When do I need an IND ? FDA Guidance for Industry – Investigation New Drug Applications (INDs) - Determining Whether Human Research Studies Can Be Conducted.
The Review of Your NIH Grant Application Begins Here Richard Nakamura, Ph.D. Director NIH Center for Scientific Review.
From the Lab to Market Unit 3.04 Understanding Biotechnology research & Development.
Biomedical Research Objective 2 Biomedical Research Methods.
Biomedical Research.
CHEE DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
American Evaluation Association EVALUATION 2009 November 14, 2009 Building Data Systems to Support Evaluation in a Biomedical Research and Development.
UNCLASSIFIED10/12/ :41 AM Slide 1 Division of Regulated Activities and Compliance.
Humanitarian Use Devices September 23, 2011 Theodore Stevens, MS, RAC Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and.
BIOE 301 Lecture Twenty-Two. Schedule Tuesday, April 18 FDA Thursday, April 19 Invisible Children Tuesday, April 25 Class Presentations Thursday, April.
NIH Peer Review Process – Grant Renewal
BME 301 Lecture Twenty-One. How are health care technologies managed? Examples: MRI Laparoscopic cholecystectomy Vitamin C treatment for scurvy Research.
BME 301 Lecture Twenty-Three. How are health care technologies managed? Examples: MRI Laparoscopic cholecystectomy Vitamin C treatment for scurvy Research.
BIOE 301 Lecture Seventeen. Progression of Heart Disease High Blood Pressure High Cholesterol Levels Atherosclerosis Ischemia Heart Attack Heart Failure.
The New Drug Development Process (www. fda. gov/cder/handbook/develop
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
The NIH Funding Process Peggy McCardle, PhD, MPH Child Development & Behavior Branch National Institute of Child Health & Human Development We wish to.
BIOE 301 Lecture Twenty One. Zantrex-3 One of the most popular weight loss supplements currently sold in the US One month’s supply: $50 Millions of.
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
FDA Risk Communication Nancy M. Ostrove, PhD Senior Advisor for Risk Communication Risk Communication Advisory Committee February 28, 2008.
Organizational Funding Portfolios and Beyond: Assessing the Full Research Landscape Panel Session 731 American Evaluation Association EVALUATION 2012 October.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
Clinical Trials.
How to get funded from the National Institutes of Health Minda R. Lynch, Ph.D., Chief Behavioral and Cognitive Science Research NIDA.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 3 Drug Regulation, Development, Names, and Information.
PD233: Design of Biomedical Devices and Systems (Lecture 2) Dr. Manish Arora CPDM, IISc Course Website:
Drug Development Process Stages involved in Regulating Drugs
Division of Cardiovascular Devices
Final Rule for Preventive Controls for Human Food
U.S. FDA Center for Devices and Radiological Health Update
Clinical Trials — A Closer Look
The Influence of Domain-Specific Metric Development on Evaluation and Design: An Example from National Institutes of Health Technology Development Programs.
Medical Device Regulatory Essentials: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
A Real World Application of the Scientific Method
Objective 2 Biomedical Research Methods
Compounded Drugs and Lack of Premarket FDA-Approval
Pharmaceuticals Industry
Presentation transcript:

BIOE 301: Lecture 22 Role of the Food and Drug Administration Nadhi Thekkek Department of Bioengineering, Rice University April 8, 2008 Rice University

Agenda FDA’s role in: Drugs Devices What does it take to approve new technologies? Rice University

Benefits of Dietary Supplements Vitamin C to prevent scurvy –Mid-18 th century: Scurvy killed more British sailors than war Folic acid to prevent neural tube defects Calcium to prevent osteoporosis Vitamin B 12 to prevent dementia Research in Alternative Medicine: – Rice University

Impact of No Regulation Sulfanilimide (1937) –Antibiotic for streptococcal infections, used safely as a pill for years –Most children can’t swallow pills –One company in Tennessee found they could dissolve drug in ethylene glycol (antifreeze) –Tested for flavor, appearance, fragrance, NOT for toxicity Rice University

Impact of No Regulation 137 children died –Severe abdominal pain, nausea, vomiting, convulsions Rice University 1938 Food, Drug, and Cosmetic Act Gave FDA authority it needed to regulate such products

Misfortune, disaster, & tragedy Lead to reforms in drug and device regulation Rice University

“Take Aways” from Last Class Strategies to speed up diffusion are important to disseminating new life saving technologies Historical precedents have set the tone for current regulation of drugs and dietary supplements It does not end here – more regulation is needed… Rice University

Recent Events Toothpaste, other imports “ The [FDA] has placed a hold on five types of farmed fish and seafood containing traces of antifungal and antibiotic drugs that are potentially harmful to humans…” “The popular Thomas and Friends Wooden Railway toys were voluntarily recalled in early June due to the presence of lead in some of the surface paints. The recall was particularly troubling for parents whose children have been playing – and chewing – on the toys for years.” Rice University

Challenges of Health Technology Regulation in Developing Countries Commerce becomes increasingly global Government of Panama manufactured cold medicines – imported what they thought was glycerin –Was actually diethylene glycol, falsely certified –Panamanian children began to die Rice University

FDA Regulates products whose annual sales account for ¼ of consumer spending in US Responsible for ensuring SAFETY and EFFICACY of CHEMICAL, BIOLOGICAL agents and sophisticated medical DEVICES Safe: –Probable benefits to health for intended use outweigh any probable risk of harm Effective: –Device does what it is supposed to do in a reliable fashion Rice University

History of Regulation 1906 –First federal regulation of drugs –Pure Food and Drug Act –As a results of activism (Upton Sinclair and others…) 1938 –Food, Drug and Cosmetic Act –As a result of Sulfanilimide tragedy Rice University

History of Regulation 1962 –Drug amendments to FD&C Act 1976 –Medical Device Amendments to FD&C Act 1994 –Dietary Supplement Health & Education Act “…dietary ingredients used in dietary supplements are no longer subject to the premarket safety evaluations required of other new food ingredients or for new uses of old food ingredients…” Rice University

1906 Pure Food and Drug Act –Label could not contain any statement regarding therapeutic effect which is false and fraudulent FDA could act only after drugs were marketed Was not enough to show that product did not work Had to show that seller knew the claims it made were false Rice University

1938 Food, Drug and Cosmetic Act –New Drugs: Could not be marketed without first notifying the FDA and allowing agency time to assess safety Beginning of era in which it is illegal to market a new drug without FDA approval –Seller’s belief regarding product’s value was no longer relevant –Issue – does the product really work? Rice University

1962 Drug Amendments to FD&C Act: –FDA must review evidence of drug safety and effectiveness –Converted pre-market notification system into pre-market approval system –Evidence of safety and efficacy must come from well-controlled investigations by qualified experts FDA has the authority to prevent harm before it occurs Rice University

Drug Approval Process Pre-clinical testing (cell, animal) occurs first –Assess toxicity Investigational New Drug (IND) Human clinical trials allowed with IND –Phase 1, 2, 3 clinical trials Manufacturer files NDA (New Drug Application) for permission to market new drug Rice University

Phases of Clinical Trials Phase 1: –Goal: safety of compound –Low doses administered to small group of healthy volunteers – volunteers Phase 2: –Goal: effectiveness of compound – patients who suffer from condition Phase 3: –Final step before seeking FDA approval –Randomized clinical trial Rice University

Post-Market Surveillance Phase 4: –Study longer term effects of drug exposure –Report adverse effects to FDA Rice University

Not Many Drugs Make It For every 5,000-10,000 drugs that enter pre-clinical testing ONE makes it to market Cost of developing one new drug: –$360 million-$800 million Rice University

Post-Marketing Surveillance Vioxx – withdrawn from market Celebrex – black box warning Bextra – sales suspended http:// http:// http:// Rice University

Regulation of Medical Devices FDA did not regulate devices before : –FDA could only challenge sale of products it believed were unsafe –Could only remove them from the market after patient injuries 1960s: –Rapid innovation in medical technology –Tried to regulate many as drugs: contact lenses, IUDs –Catastrophic failures of heart valves and pacemakers 1970s: –Broad recognition that different rules were needed to regulate devices

1976 Device amendments to FD&C Act: –No single policy would work for all devices Tongue depressor Artificial heart –Three classes of devices would be used to regulate new technologies Rice University

Three classes of devices… Class I: Pose least risk to patient Not life sustaining GMP, proper record keeping required 30% of devices X-ray film, tongue depressors, stethoscopes Class II: Not life sustaining, but must meet performance standards Blood pressure monitors, Catheter guide wires 60% of devices Class III: Pose greatest risk to patient For use in supporting or sustaining human life 10% of devices Stents, heart valves, LVADs Require GMP, failure modes analysis, animal tests, human clinical studies under IDE Rice University

Role of CDRH Ensure that products coming to market have more benefit than risk Ensure that products are labeled so that practitioners and patients know what to expect from their use Regulates 1,700 types of devices 23,000 registered manufacturers 1996: received 20,236 device related submissions Rice University

Device Approval Process Device + intended use considered together Manufacturer submits request for marketing approval Advisory panel: –One consumer representative (non-voting) –One industry representative (non-voting) –Physicians and scientists FDA not required to follow recommendations of panel, although they usually do Rice University

IDE Investigational Device Exemption –Enables experimental use of high risk device –Must have positive engineering and animal data –First give approval for feasibility studies with small number of patients –Then proceed to multi-center trials –Larger data sets frequently show results from small sample sets are not true Rice University

Humanitarian Use Exemption Device designed to treat or diagnose condition that affects <4,000 patients/year Device would not otherwise be available without exemption No comparable device is available Patients will not be exposed to unreasonable or significant risk of injury or illness by device Rice University

Medical Device Reporting System to detect device related problems in a timely manner Serious injuries or deaths that may have been caused by or related to a a medical device must be reported to the manufacturer of the device within 10 days Must be reported to the FDA within 10 days Rice University

Recently Approved Devices Rice University

Who Funds R&D? Who Does R&D? be/srs/seind02/c4/fig gif

Types of Universities Carnegie Classification –Taxonomy of colleges and universities Doctorate-Granting Institutions –Research Universities /Very High Research Activity –Research Universities/ High Research Activity –Doctoral/Research Universities Master’s Colleges & Universities Baccalaureate Colleges – preview.org/index.aspxhttp:// preview.org/index.aspx Rice Rice University

Total Research Rice Rice University

R&D Funding for Biomedical Research Federal government: –Funds ~ 36% of all medical research in US Mostly funded through NIH:NIH –Current NIH budget: $28 billion/year –NIH budget doubled from –This year: 0% increase –Focus is on basic research Rice University

US Senate Report – May, drugs introduced between 1965 and 1992: –Considered by experts to have had highest therapeutic impact on society –Public funding of research was instrumental in development of 15 of the 21 drugs (71%) –Three-captopril (Capoten), fluoxetine (Prozac), and acyclovir (Zovirax)-had more than $1 billion in sales in 1994 and 1995 –Others, including AZT, acyclovir, fluconazole (Diflucan), foscarnet (Foscavir), and ketoconazole (Nizoral), had NIH funding and research to help in clinical trials Rice University

NIH National Cancer Institute National Eye Institute National Heart, Lung, and Blood Institute National Human Genome Research Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute of Child Health and Human Development National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute on Drug Abuse National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Neurological Disorders and Stroke National Institute of Nursing Research National Library of Medicine

The Funding Process NIH  Issues request for proposals Investigator  Writes a proposal –Hypothesis –Background & Significance –Preliminary Results –Research Design and Methods –Protection of Animals and Human Subjects Peer-Review –Score –Comments Institutional Review Funding Decision Rice University

Scores 1/3 Unscored 2/3 Scored –100 best –500 worst –Typically need score of to be funded –Approximately 10-15% of submitted proposals are funded Summary sheet Rice University

“Take Aways” What were two major laws that were enacted to give the FDA more regulatory responsibilities? What were three amendments made to the Food, Drug, and Cosmetic Act that have impacted the way drugs, technology, and supplements are regulated? Know the different phases of clinical trials and why they are significant… What are the different classes of devices? What sort of controversy surrounds Vioxx? Rice University